Navigation Links
Stemline Therapeutics Announces Two Presentations of Direct Injection Synthetic Peptide Vaccine for Brain Cancer, Now Being Developed as SL-701, at the Annual Meeting of the American Association of Cancer Research (AACR)
Date:4/18/2012

NEW YORK, April 18, 2012 /PRNewswire/ -- Stemline Therapeutics, Inc. announced that trial results of two clinical studies of direct injection synthetic peptide vaccine, now being developed as SL-701, in both adults and children with advanced brain cancer were selected for late-breaking presentations at the Annual Meeting of the American Association for Cancer Research (AACR) held from March 31 to April 4, 2012 in Chicago, IL. SL-701 is comprised of synthetic peptides corresponding to epitopes of targets overexpressed on glioblastoma multiforme (GBM) and other high-grade and low-grade gliomas and administered via direct subcutaneous injection. The data were presented by investigators at the University of Pittsburgh (Pitt), who developed the direct injection synthetic peptide vaccine. In 2009, the University of Pittsburgh licensed patent rights relating to the vaccine to Stemline.

In the pediatric study conducted by the Pitt team and led by Dr. Ian Pollack, 27 children were enrolled, including 16 with newly diagnosed brainstem glioma (BSG), five with newly diagnosed cerebral high grade glioma (HGG), and six with recurrent gliomas. Children were treated with the Pitt synthetic peptide vaccine, administered via direct subcutaneous injection, every three weeks for up to eight courses. Among 22 evaluable children who were HLA-A2-positive, three had sustained partial responses (PRs) including one exceeding 15 months, one had prolonged disease free status following surgery, and 14 had stable disease lasting longer than three months. In addition, the results of ELISPOT immunological assays revealed specific T-cell responses to the intended targets in six of seven children evaluated. Systemic side effects were minimal. Tumor pseudoprogression, which is transient tumor enlargement due to inflammation followed by tumor stabilization or shrinkage, occurred in four children. The research team concluded that the direct injection synthetic peptide vaccine, now being
'/>"/>

SOURCE Stemline Therapeutics, Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Stemline Therapeutics Appoints Kevin Buchi, Former CEO of Cephalon, to Its Board of Directors
2. Stemline Therapeutics, Inc. Names Eric K. Rowinsky, M.D. Chief Medical Officer and Head of Research and Development
3. Stemline Therapeutics Expands Clinical Oncology Program Directed at Cancer Stem Cells With Addition of M.D. Anderson Cancer Center
4. Nile Therapeutics, Inc. Completes $1.34 Million Registered Direct Offering
5. Nile Therapeutics, Inc. to Raise $1.4 Million in Registered Direct Offering
6. Amsterdam Molecular Therapeutics Announces Results of Extraordinary General Meeting
7. Particle Sciences and Pernix Therapeutics Enter into an Agreement to Develop a Pediatric Dermatology Product
8. Tarsa Therapeutics Signs Commercial Supply Agreement for its Ostora™ Oral Calcitonin Product With QS Pharma
9. Novation Releases Its Latest Transcatheter Cardiovascular Therapeutics Report to Help Members Understand and Prepare for New Technologies
10. Halo Therapeutics Reports Favorable Independent Review of Lead Drug Candidate HT-100
11. Echo Therapeutics, Inc. Announces 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... 28, 2014 Alimera Sciences, Inc. (NASDAQ: ... that specializes in the research, development and commercialization ... Securities Purchase Agreement with Deerfield Management and certain ... will issue shares of preferred stock to Deerfield ... million upon the satisfaction of certain closing conditions. ...
(Date:11/28/2014)... HK$,000Six months endedChange %  30 September 201430 September 2013Turnover 546,011 , ... , 384,242 , 339,113 , 13.3 ... 41,377 , 49.5 Medical Insurance Administration Service Income ... Medical Devices and Accessories Sales , 94,580 , ... 2,917 , 9,219 , (68.4) Impairment Loss ...
(Date:11/27/2014)... November 27, 2014 Hovione announced ... (IND) Application with the U.S. Food and Drug Administration ... of developing improved drug delivery options for established drugs. ... a novel formulation using a new patented crystalline base ... most widely prescribed oral antibiotics for acne. Currently, there ...
Breaking Medicine Technology:Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing 2Alimera Sciences Announces Agreement with Deerfield Management for $50.0 Million Financing 3Golden Meditech Announces 2014 / 2015 Interim Results 2Golden Meditech Announces 2014 / 2015 Interim Results 3Golden Meditech Announces 2014 / 2015 Interim Results 4Golden Meditech Announces 2014 / 2015 Interim Results 5Golden Meditech Announces 2014 / 2015 Interim Results 6Golden Meditech Announces 2014 / 2015 Interim Results 7Golden Meditech Announces 2014 / 2015 Interim Results 8Hovione Files its First Investigational New Drug Application With the FDA 2
... Biotica Technology,Limited, a privately-held biotechnology company, announces ... to discover, develop,and commercialise novel erythromycin-based macrolides ... In a three year research collaboration, Biotica ... that are not readily,accessible via conventional medicinal ...
... 9 Anesiva, Inc.,(Nasdaq: ANSV ) ... Administration,(FDA) has approved Anesiva,s supplemental New Drug Application ... the pain associated with blood,draws to include adults. ... previously approved to treat the pain,associated with peripheral ...
Cached Medicine Technology:Biotica Strikes Significant Collaboration Deal With GlaxoSmithKline 2Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication 2
(Date:11/28/2014)... Written and narrated by award winning author Dr. James ... Happiest Man In the World: Life Lessons From a Cultural ... Project C.U.R.E. came to be. , Raised in the Boise ... Richard W. Jackson, Dr. Jackson exceeded his goal of being ... he wasn’t happy. Prompted by this realization, James and his ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Not only ... create products free of petroleum, parabens and other cancer-causing ... that fund research, education and awareness programs that help ... staff and owners have raised an incredible, record-breaking contribution ... the Cure, sales of the Sweet Red Rose Whip ...
(Date:11/28/2014)... Hamilton, ON Canada (PRWEB) November 28, 2014 ... labels for the stuff kids lose® and an award-winning ... Julie Cole, Julie Ellis, Cynthia Esp, and Tricia Mumby ... Entrepreneur Award. They were recognized with the PROFIT Award ... Cole, Julie Ellis, Cynthia Esp, and Tricia Mumby) accepted ...
(Date:11/28/2014)... Lice Troopers Lice Removal Service is pleased to ... lice service for moms in Miami-Dade County. Lice Troopers is ... on Pone De-leon Blvd in Miami. The company currently ... Miami-Dade & Broward. Lice Troopers is the only Lice Clinic ... been treating families for several years. , Lice Troopers estimate ...
(Date:11/28/2014)... Schools like Centra Rivermont understand the therapeutic ... equipment to its students. That is why the ... play structure at its mental health services facility ... programs for children who are identified as needing ... have served the needs of children with severe ...
Breaking Medicine News(10 mins):Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 3Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 2Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 3Health News:Lice Troopers Lice Removal Service Expands in Miami-Dade 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 3
... , NEW YORK, July 21 BET News correspondent, Andre ... Obama,s news conference in Washington on Wednesday, July 22 ( ... BET J will re-air an encore broadcast of the entire news conference ... Sophia Nelson at 10:00 p.m. The President is expected ...
... KALAMAZOO, Mich., July 21 Stryker Corporation (NYSE: SYK ) reported ... , Second Quarter Highlights , ... million were flat (0.1% decrease) on a constant currency basis (4.6% decrease as ... constant currency basis (0.2% decrease as reported) , MedSurg ...
... , , ALISO VIEJO, Calif., July 21 ... it will host a conference call and a live Internet webcast along ... EDT (7:00 a.m. PDT) to discuss results for the 2009 second quarter. ... on this call is (877) 295-5743, confirmation code 20797641. International callers ...
... MEQUON, Wis., July 21 Wonderbox Technologies has released version ... from continued advances in technology and software features. Central to ... managed care benefit administration and case management. The Care Management ... and monitoring day-to-day care tasks and case assignments. , ...
... , , NEW YORK, July ... action against MetLife. The class action involves MetLife,s April 2000 conversion ... class action certified by the Federal Court in New York includes ... , The notice of the class action ...
... on how they help arteries stay clear and healthy , ... technology, researchers have begun to discover the exact molecular reasons ... -- and ordinary orange juice are good for the health ... reporting studies describing the range of genes that are affected ...
Cached Medicine News:Health News:BET Networks Airs Special Coverage of President Obama's News Conference on Health Care 2Health News:Stryker Operating Results for Quarter Ended June 30, 2009 2Health News:Stryker Operating Results for Quarter Ended June 30, 2009 3Health News:Stryker Operating Results for Quarter Ended June 30, 2009 4Health News:Stryker Operating Results for Quarter Ended June 30, 2009 5Health News:Stryker Operating Results for Quarter Ended June 30, 2009 6Health News:Stryker Operating Results for Quarter Ended June 30, 2009 7Health News:Stryker Operating Results for Quarter Ended June 30, 2009 8Health News:Stryker Operating Results for Quarter Ended June 30, 2009 9Health News:Stryker Operating Results for Quarter Ended June 30, 2009 10Health News:Valeant Pharmaceuticals to Announce 2009 Second Quarter Results on August 4, 2009 2Health News:Wonderbox Technologies(R) Releases Version 4.5 of the Enterprise System 2Health News:Notice Begins Announcing Pendency of a Class Action Regarding MetLife 2Health News:Notice Begins Announcing Pendency of a Class Action Regarding MetLife 3Health News:Studies Show Genetic Activity of Antioxidants 2Health News:Studies Show Genetic Activity of Antioxidants 3
... BioCheck FSH EIA Test is ... a solid phase enzyme-linked immunosorbent ... mouse monoclonal anti-FSH for solid ... sheep anti-alpha FSH in the ...
This ELISA test is used for the detection and semi-quantitation of lgG antibobies to proteinase 3(pr3) in human sera, as an aid to the diagnosis of wegener s granulomatosis....
... glygoprotein produced by the anterior pituitary gland. Like ... FSH consists of subunits designated as alpha and ... sandwich ELISA method. The samples and diluted anti-FSH-HRP ... Mab to FSH beta subunit. FSH in the ...
... is a glycoprotein hormone secreted by ... LH and TSH, the intact FSH ... of alpha- and beta-subunits. Its production ... hormone (GnRH) from the hypothalamus. GnRH ...
Medicine Products: